1. Senju, Chikako, Nakazawa, Yuka, Oso, Taichi, Nishigori, Chikako, Ogi, Tomoo. 2023. Deep intronic founder mutations identified in the ERCC4/XPF gene are potential therapeutic targets for a high-frequency form of xeroderma pigmentosum. In Proceedings of the National Academy of Sciences of the United States of America, 120, e2217423120. doi:10.1073/pnas.2217423120. https://pubmed.ncbi.nlm.nih.gov/37364129/
2. Kohlhase, Sandra, Bogdanova, Natalia V, Schürmann, Peter, Schindler, Detlev, Dörk, Thilo. 2014. Mutation analysis of the ERCC4/FANCQ gene in hereditary breast cancer. In PloS one, 9, e85334. doi:10.1371/journal.pone.0085334. https://pubmed.ncbi.nlm.nih.gov/24465539/
3. Osorio, Ana, Bogliolo, Massimo, Fernández, Victoria, Surrallés, Jordi, Benítez, Javier. 2013. Evaluation of rare variants in the new fanconi anemia gene ERCC4 (FANCQ) as familial breast/ovarian cancer susceptibility alleles. In Human mutation, 34, 1615-8. doi:10.1002/humu.22438. https://pubmed.ncbi.nlm.nih.gov/24027083/
4. Kulikowska, Joanna, Jakubiuk-Tomaszuk, Anna, Rydzanicz, Małgorzata, Kulakowska, Alina, Kapica-Topczewska, Katarzyna. 2023. Case report: Variants in the ERCC4 gene as a rare cause of cerebellar ataxia with chorea. In Frontiers in genetics, 14, 1107460. doi:10.3389/fgene.2023.1107460. https://pubmed.ncbi.nlm.nih.gov/36816046/
5. Shi, Runjie, Wang, Shanping, Jiang, Ying, Li, Mingsong, Sun, Yan. 2024. ERCC4: a potential regulatory factor in inflammatory bowel disease and inflammation-associated colorectal cancer. In Frontiers in endocrinology, 15, 1348216. doi:10.3389/fendo.2024.1348216. https://pubmed.ncbi.nlm.nih.gov/38516408/
智鼠故事 
